Vitis vinifera L. Leaf Extract Inhibits In Vitro Mediators of Inflammation and Oxidative Stress Involved in Inflammatory-Based Skin Diseases
暂无分享,去创建一个
S. Piazza | M. Dell’Agli | P. Restani | C. Di Lorenzo | F. Colombo | L. Marabini | M. Fumagalli | A. Casiraghi | G. Melzi | E. Sangiovanni | G. Martinelli | A. Magnavacca | Y. Manzoni | C. Brunelli | Chiara Di Lorenzo
[1] F. Romeo,et al. Bioactive compounds and antioxidant activity of four rose hip species from spontaneous Sicilian flora. , 2019, Food chemistry.
[2] S. Piazza,et al. In vitro evidences of the traditional use of Rhus coriaria L. fruits against skin inflammatory conditions. , 2019, Journal of ethnopharmacology.
[3] A. Romani,et al. In vitro studies on anti-inflammatory activities of kiwifruit peel extract in human THP-1 monocytes. , 2019, Journal of ethnopharmacology.
[4] J. A. Ataide,et al. In vitro antioxidant activity and solar protection factor of blackberry and raspberry extracts in topical formulation , 2019, Journal of cosmetic dermatology.
[5] N. Lacetera,et al. Anti-Inflammatory Effects of Pomegranate Peel Extracts on In Vitro Human Intestinal Caco-2 Cells and Ex Vivo Porcine Colonic Tissue Explants , 2019, Nutrients.
[6] P. Minghetti,et al. Emulsion versus nanoemulsion: how much is the formulative shift critical for a cosmetic product? , 2018, Drug Delivery and Translational Research.
[7] M. Dell’Agli,et al. HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes , 2017, Mediators of inflammation.
[8] Wei Wang,et al. DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression , 2017, Journal of cancer metastasis and treatment.
[9] T. Radhiga,et al. Phytochemicals as modulators of ultraviolet-b radiation induced cellular and molecular events: A review , 2016 .
[10] M. Dell’Agli,et al. The effect of in vitro gastrointestinal digestion on the anti-inflammatory activity of Vitis vinifera L. leaves. , 2015, Food & function.
[11] A. Zhang,et al. Plant extracts for the topical management of psoriasis: a systematic review and meta‐analysis , 2013, The British journal of dermatology.
[12] J. Pereira,et al. Vitis vinifera leaves towards bioactivity , 2013 .
[13] A. Offidani,et al. Oxidative stress and psoriasis: the effect of antitumour necrosis factor‐α inhibitor treatment , 2013, The British journal of dermatology.
[14] A. Gottlieb,et al. NF-κB: an essential transcription factor in psoriasis. , 2013, Journal of dermatological science.
[15] Liu Wei-na,et al. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. , 2012, International journal of pharmaceutics.
[16] A. Knulst,et al. Evaluation of the child with atopic dermatitis , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[17] H. Norsgaard,et al. Psoriasis drug discovery: methods for evaluation of potential drug candidates , 2012, Expert opinion on drug discovery.
[18] M. Stücker,et al. Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency--results of a double-blind placebo-controlled study. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[19] M. Pasparakis,et al. NF-κB in the regulation of epithelial homeostasis and inflammation , 2011, Cell Research.
[20] J. Gelfand,et al. Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. , 2009, Journal of the American Academy of Dermatology.
[21] Frank O. Nestle,et al. Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.
[22] Frank O. Nestle,et al. Mechanisms of Disease: Psoriasis. , 2009 .
[23] Nilüfer Orhan,et al. Biological Screening of Vitis vinifera L. Leaf Fractions , 2009 .
[24] Nilüfer Orhan,et al. Biological activities of Vitis vinifera L. leaves , 2009 .
[25] M. Detmar,et al. Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. , 2008, The American journal of pathology.
[26] E. Berardesca,et al. Effective Therapy with Anti‐TNF‐α in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions , 2007, Annals of the New York Academy of Sciences.
[27] Jae-We Cho,et al. Curcumin attenuates the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets , 2007 .
[28] Jae-We Cho,et al. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. , 2007, International journal of molecular medicine.
[29] F. Nestle,et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial , 2005, The Lancet.
[30] N. Scheinfeld. A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab , 2004, The Journal of dermatological treatment.
[31] A. Schrader,et al. Transdermal delivery of two antioxidants from different cosmetic formulations , 2003, International journal of cosmetic science.
[32] D. Sauder,et al. Neovastat (AE-941), an inhibitor of angiogenesis: Randomized phase I/II clinical trial results in patients with plaque psoriasis. , 2002, Journal of the American Academy of Dermatology.
[33] S. Rantapää Dahlqvist,et al. Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis. , 2001, Clinical and experimental rheumatology.
[34] E. Christophers. Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.
[35] M. Diaz,et al. Abnormal NF-kappaB signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes. , 2001, Journal of dermatological science.
[36] B. Nickoloff. Skin innate immune system in psoriasis: friend or foe? , 1999, The Journal of clinical investigation.
[37] H. Dvorak,et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis , 1994, The Journal of experimental medicine.
[38] E. Farber,et al. The natural history of psoriasis in 5,600 patients. , 1974, Dermatologica.